Cargando…
The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway
Ebola virus (EBOV) expresses three different glycoproteins (GPs) from its GP gene. The primary product, soluble GP (sGP), is secreted in abundance during infection. EBOV sGP has been discussed as a potential pathogenicity factor, however, little is known regarding its functional role. Here, we analy...
Autores principales: | Furuyama, Wakako, Shifflett, Kyle, Feldmann, Heinz, Marzi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478236/ https://www.ncbi.nlm.nih.gov/pubmed/34529738 http://dx.doi.org/10.1371/journal.ppat.1009937 |
Ejemplares similares
-
Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
por: Bhatia, Bharti, et al.
Publicado: (2021) -
Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection
por: Furuyama, Wakako, et al.
Publicado: (2020) -
The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
por: Suder, Ellen, et al.
Publicado: (2018) -
Development of an imaging system for visualization of Ebola virus glycoprotein throughout the viral lifecycle
por: Furuyama, Wakako, et al.
Publicado: (2022) -
The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo
por: Groseth, Allison, et al.
Publicado: (2012)